Gyre Therapeutics, Inc. · NASDAQ:GYRE
Luo Ying sold 10,315 Gyre Therapeutics, Inc. shares (Form 4)
Traded May 5 to May 6, 2026 · Filed May 7, 2026
From May 5 to May 6, 2026, Luo Ying (Director, Chief Executive Officer) sold 10,315 Gyre Therapeutics, Inc. shares at an average US$8.04 for US$82,927 under a trading plan, leaving 2,565,226 shares. Filed May 7, 2026 (Form 4).
- Sold
- 10,315 shares
- Price
- US$8.04 average (US$8.01 to US$8.04)
- Value
- US$82,927
- Holding after
- 2,565,226 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Sale | 179 | US$8.01 | 2,575,362 | Indirect |
| May 6, 2026 | Common Stock | Sale | 10,136 | US$8.04 | 2,565,226 | Indirect |